Focal gains of VEGFA: candidate predictors of sorafenib response in hepatocellular carcinoma
- PMID: 24823635
- PMCID: PMC4071286
- DOI: 10.1016/j.ccr.2014.04.019
Focal gains of VEGFA: candidate predictors of sorafenib response in hepatocellular carcinoma
Abstract
Focal amplifications in 6p21 containing the VEGFA locus occur in 7%-10% of hepatocellular carcinoma (HCC). A recent paper describes how VEGF-A stimulates paracrine secretion of hepatocyte growth factor by stromal cells, which induces tumor progression. HCC patients with VEGFA amplification are distinctly sensitive to sorafenib.
Copyright © 2014 Elsevier Inc. All rights reserved.
References
-
- Bruix J, Raoul JL, Sherman M, Mazzaferro V, Bolondi L, Craxi A, Galle PR, Santoro A, Beaugrand M, Sangiovanni A, et al. J Hepatol. 2012;57:821–829. - PubMed
-
- Horwitz E, Stein I, Andreozzi M, Nemeth J, Shoham A, Pappo O, Schweitzer N, Tornillo L, Kanarek N, Quagliata L, et al. Cancer Discov. 2014 [Epub ahead of print] - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
